GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042221 |
response to chemical
|
ABCB1, ABCG2, ADORA2A, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, KIT, MMP2, MMP9, PPARA, RORC, SRC, TERT, TOP1, TYR |
10.0568 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
9.69569 |
[BP] GO:0010033 |
response to organic substance
|
ADORA2A, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, KIT, MMP2, PPARA, RORC, SRC, TYR |
8.36252 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, FABP3, HMGCR, HSD17B2, IGF1R, MMP2, MMP9, PPARA, RORC, SRC, TYR |
8.21612 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, FUT7, HMGCR, HSD17B1, HSD17B2, KIT, MET, PPARA |
7.84484 |
[BP] GO:0044281 |
small molecule metabolic process
|
ABCG2, ADORA2A, AKR1B1, AKR1B10, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, HMGCR, PIM1, PPARA, TYR, XDH |
7.42989 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADORA2A, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, FLT3, HCAR2, HMGCR, KDR, KIT, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
6.99173 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADORA2A, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, FLT3, HCAR2, HMGCR, KDR, KIT, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
6.99114 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.9006 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, F10, FABP3, FABP4, FLT3, HCAR2, HMGCR, HSD17B1, HSD17B2, KDR, KIT, MET, PPARA, SRC, TERT, XDH |
6.9006 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, KIT, MMP9, SRC, TERT |
6.71437 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, F10, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SRC, TERT, TOP1, TYR |
6.69977 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, HMGCR, HSD17B1, HSD17B2 |
6.46284 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA2A, ADORA3, AKR1B1, APP, BCL2, CDC25B, CSNK2A1, CYP1B1, DNMT1, FABP3, FLT3, HMGCR, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, SRC, TERT, XDH |
6.45184 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, FLT3, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT, XDH |
6.4479 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT |
6.34444 |
[BP] GO:0008152 |
metabolic process
|
ABCG2, ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, F10, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TOP1, TYR, XDH |
6.34444 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, FLT3, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
6.34444 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, RORC, SRC, TYR |
6.34444 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADORA2A, CA2, CA7, CNR1, CNR2 |
6.26074 |
[BP] GO:0042493 |
response to drug
|
ABCB1, ABCG2, ADORA2A, AKR1B1, AXL, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, FABP3, HMGCR, KDR, SRC, TOP1 |
6.24822 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTPN1, SRC, TERT |
6.15416 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.99481 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, F10, FABP3, FLT3, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, XDH |
5.81311 |
[BP] GO:0044237 |
cellular metabolic process
|
ABCG2, ACHE, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, F10, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP2, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TOP1, TYR, XDH |
5.76734 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, F10, FLT3, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
5.71713 |
[BP] GO:0009636 |
response to toxic substance
|
ADORA2A, AKR1B1, ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, HMGCR, KDR, SRC |
5.62403 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, F10, FLT3, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
5.62403 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, F10, FABP3, FABP4, FLT3, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, XDH |
5.54856 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, F10, FABP4, HMGCR, HSD17B2, IGF1R, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TOP1, TYR |
5.5437 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.5437 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ADORA2A, ALPL, APP, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FLT3, RORC, SRC, TYR |
5.5437 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, APP, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, F10, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PPARA, PTPN1, SRC, TERT |
5.53119 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, PIM1, SRC |
5.277 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, FABP4, FLT3, FUT7, HMGCR, HSD17B2, KDR, KIT, MET, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TERT, TYR |
5.16463 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, FABP3, FLT3, HCAR2, HMGCR, KIT, PPARA, RORC, SRC |
5.11063 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, FLT3, HCAR2, HMGCR, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
5.08004 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADORA2A, AKR1B1, APP, AXL, BCL2, CSNK2A1, CYP1B1, F10, FLT3, HMGCR, KDR, KIT, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
5.05234 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADORA2A, APP, BACE1, CA2, CA7, CNR1, CNR2, KIT |
4.84908 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADORA2A, APP, BACE1, CA2, CA7, CNR1, CNR2, KIT |
4.84908 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, FUT7, HMGCR, KIT, MET, PPARA |
4.84712 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, FABP3, FLT3, IGF1R, KIT, MMP2, PPARA, SRC |
4.75454 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT |
4.73871 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADORA2A, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, HCAR2, HMGCR, HSD17B1, HSD17B2 |
4.69305 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, ADORA2A, APP, CNR1, CNR2, CYP19A1, DYRK1A, FABP4, HMGCR, IGF1R, MET, MMP12, MMP2, PPARA, PTPN1, SRC, TERT, XDH |
4.61898 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADORA2A, AKR1B1, APP, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, F10, FABP4, FLT3, HMGCR, KDR, KIT, MET, MMP12, MMP2, MMP9, PTPN1, SRC, TERT, XDH |
4.56554 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA2A, ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, FABP4, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
4.56554 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA2A, ADORA3, APP, BCL2, CYP19A1, CYP1B1, F10, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.54179 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DNMT1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, RORC, SRC, TERT |
4.54075 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, F10, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.48059 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.39851 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
4.39851 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
4.35157 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP1 |
4.31811 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, F10, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.20529 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADORA2A, AURKB, BCL2, CA2, CA7, CNR1, HCAR2, HMGCR, KDR, SRC |
4.14324 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DYRK1A, KIT, PPARA, RORC, SRC, TOP1 |
4.13717 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
4.13717 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AXL, BCL2, CYP1B1, F10, FLT3, HMGCR, KDR, KIT, MET, PTPN1, SRC, XDH |
4.13167 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ADORA2A, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DYRK1A, FLT3, HMGCR, IGF1R, KDR, KIT, MET, PIM1, PTPN1, SRC, TOP1, XDH |
4.11281 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, F10, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PTPN1, SRC, XDH |
3.98111 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.92911 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CSNK2A1, FLT3, HMGCR, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, TERT |
3.8855 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, F10, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.84264 |
[BP] GO:0010243 |
response to organonitrogen compound
|
ADORA2A, AKR1B1, APP, CNR1, CNR2, DNMT1, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TYR |
3.84145 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HMGCR, HSD17B1, HSD17B2, TYR, XDH |
3.84145 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ADORA2A, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DYRK1A, FLT3, HMGCR, IGF1R, KDR, KIT, MET, PIM1, PTPN1, SRC, TOP1, XDH |
3.83173 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.83137 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, KIT, MMP9, TERT |
3.79759 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
3.79257 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.75767 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, RORC, SRC |
3.74325 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, KIT, PPARA, SRC |
3.70922 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.69392 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, F10, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TOP1, TYR, XDH |
3.69392 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.69392 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.65384 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.65384 |
[BP] GO:0071704 |
organic substance metabolic process
|
ABCG2, ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, F10, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TOP1, TYR, XDH |
3.63911 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, F10, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.62709 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, XDH |
3.62709 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.62709 |
[BP] GO:1901698 |
response to nitrogen compound
|
ADORA2A, AKR1B1, APP, CNR1, CNR2, DNMT1, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TYR |
3.55547 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, F10, FABP4, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP2, MMP9, PPARA, PTPN1, SRC, TERT, XDH |
3.51136 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, FLT3, HSD17B2, KDR, KIT, MMP9, PIM1, PPARA, RORC, SRC, TYR |
3.51136 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, F10, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.51136 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.44549 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, F10, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.41786 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP1 |
3.38959 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, HMGCR, KIT, MMP2, PPARA, SRC, TERT, TYR |
3.37665 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADORA2A, BCL2, CNR1, CNR2, CYP19A1, DYRK1A, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, SRC, TERT, XDH |
3.37617 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DNMT1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, PTPN1, RORC, SRC, TERT |
3.37289 |
[BP] GO:0001973 |
None
|
ADORA1, ADORA2A, ADORA3 |
3.34617 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ADORA2A, APP, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, HCAR2, HMGCR, MMP12, MMP9, PPARA, PTPN1, SRC, TERT |
3.34433 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, F10, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.31337 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DYRK1A, F10, FLT3, IGF1R, KDR, KIT, MET, SRC, TOP1 |
3.29766 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, KDR, KIT, PPARA, SRC, TYR |
3.27038 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PTPN1, SRC |
3.23776 |
[BP] GO:0042592 |
homeostatic process
|
ABCG2, ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CNR1, FABP3, FABP4, FLT3, MET, SRC, TERT |
3.23418 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ABCG2, ACHE, ADORA2A, AKR1B1, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, DYRK1A, F10, FLT3, FUT7, HMGCR, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, SRC, TOP1, TYR, XDH |
3.23216 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADORA2A, APP, AXL, BCL2, CA2, CNR1, CYP1B1, HCAR2, HMGCR, KDR, KIT, MET, MMP12, MMP9, PIM1, SRC, TERT |
3.23107 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.23034 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.23034 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADORA2A, APP, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DNMT1, DYRK1A, FABP4, HCAR2, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
3.19742 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA |
3.18543 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, ADORA2A, BCL2, CA2, CA7, KDR, SRC |
3.18543 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, TERT |
3.17926 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, F10, FABP3, FABP4, FLT3, FUT7, HCAR2, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TOP1, TYR, XDH |
3.17072 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.11876 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, XDH |
3.07421 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, BCL2, CYP1A1, FLT3, KIT, MET, PIM1, SRC, TYR |
3.06613 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, HMGCR, TYR |
3.06443 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, ADORA2A, CA2, CA7 |
3.04103 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, FABP3, FLT3, HMGCR, KDR, KIT, MMP9, PTPN1, SRC, XDH |
3.00395 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, FABP3, FLT3, HMGCR, KDR, KIT, MMP9, PTPN1, SRC, XDH |
3.00395 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.96706 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, ADORA2A, APP, AXL, BCL2, CA2, CYP19A1, HCAR2, MMP12, SRC, TERT |
2.93665 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.91779 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADORA2A, CA2, CA7 |
2.91779 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
2.87565 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.84679 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
2.78522 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, FABP4, FLT3, HMGCR, IGF1R, KDR, KIT, MMP9, PPARA, PTPN1, SRC, XDH |
2.77345 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADORA2A, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
2.708 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA2A, ADORA3, APP, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, FABP4, FLT3, HMGCR, IGF1R, KIT, MMP9, PTPN1, SRC, TERT, XDH |
2.69935 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
2.67293 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, ADORA2A, CNR2, CYP19A1, MMP12, PPARA |
2.66315 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SRC, TERT |
2.65144 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, KIT, MMP9, RORC |
2.63254 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.63189 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, KIT, MMP9, PPARA, PTPN1, SRC, XDH |
2.63189 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, FABP4, FLT3, HMGCR, IGF1R, KDR, KIT, MMP9, PTPN1, SRC, XDH |
2.61771 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, BCL2, CDC25B, DNMT1, DYRK1A, FLT3, HMGCR, KDR, KIT, MMP9, PTPN1, SRC, XDH |
2.61771 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, KIT, MMP9, PPARA, PTPN1, SRC, XDH |
2.59421 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SRC, TERT |
2.58697 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA2A, ADORA3, APP, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, FABP4, FLT3, HMGCR, IGF1R, KIT, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT, XDH |
2.57927 |
[BP] GO:0050994 |
None
|
ADORA1, CNR1, HCAR2, PPARA |
2.56754 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.56574 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.55322 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.55322 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, DNMT1, DYRK1A, FABP4, FLT3, HMGCR, IGF1R, KDR, KIT, MMP9, PTPN1, SRC, XDH |
2.55322 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, SRC |
2.50423 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADORA2A, APP, AURKB, BCL2, CDC25B, DNMT1, DYRK1A, FABP3, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
2.49191 |
[BP] GO:0030098 |
lymphocyte differentiation
|
AXL, BCL2, FLT3, FUT7, KIT, RORC |
2.47954 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.47954 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, KIT, MMP9, TERT |
2.4706 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.4706 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, RORC |
2.46416 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, FLT3, HMGCR, KDR, KIT, PTPN1, SRC, XDH |
2.46324 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, ADORA2A, CNR1, CNR2, CYP19A1, FABP4, HMGCR, KDR, MET, MMP12, PPARA |
2.46308 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, ADORA2A, CNR2, CYP19A1, PPARA |
2.4527 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, ADORA2A, CNR1, CNR2, CYP19A1, FABP4, MMP12, MMP2, PPARA, PTPN1, SRC |
2.44737 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADORA2A, APP, CDC25B, FABP4, FLT3, HMGCR, IGF1R, KIT, PTPN1, SRC |
2.43954 |
[BP] GO:0035588 |
None
|
ADORA1, ADORA2A, ADORA3 |
2.43738 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DYRK1A, HMGCR, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
2.43708 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, BCL2, CDC25B, FLT3, HMGCR, KDR, KIT, MMP9, PTPN1, SRC, XDH |
2.41958 |
[BP] GO:0042391 |
None
|
ADORA1, ADORA2A, APP, BCL2, CNR1, CNR2, KDR, SRC |
2.41099 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SRC, TERT |
2.41099 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, CNR2, DYRK1A, HMGCR, IGF1R, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
2.40062 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, CNR2, DYRK1A, HMGCR, IGF1R, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
2.38794 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, SRC |
2.37913 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADORA2A, APP, CA2, CA7 |
2.37913 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADORA2A, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, FABP3, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
2.37437 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.37091 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADORA2A, APP, CA2, CNR1, HCAR2, HMGCR, MMP12, PTPN1, SRC |
2.36028 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, SRC |
2.3533 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.34687 |
[BP] GO:0050995 |
None
|
ADORA1, CNR1, HCAR2 |
2.34687 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PTPN1, SRC |
2.33389 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, HMGCR |
2.32791 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HMGCR, HSD17B1, HSD17B2 |
2.31338 |
[BP] GO:0051881 |
regulation of mitochondrial membrane potential
|
ADORA2A, BCL2, KDR, SRC |
2.30474 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.29718 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.29613 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.29257 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, TERT |
2.29257 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.29176 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, BCL2, CDC25B, FLT3, HMGCR, KDR, KIT, MMP9, PTPN1, SRC, XDH |
2.29164 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, F10, KIT, MET, SRC, XDH |
2.29164 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, F10, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
2.26521 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.26334 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.26135 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.26135 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CNR1, CYP1A1, HMGCR, SRC, TYR |
2.2445 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ADORA2A, APP, AXL, BCL2, CA2, CNR1, CNR2, CYP19A1, HCAR2, KIT, MMP12, MMP2, PTPN1, SRC |
2.24188 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, BCL2, CNR1, DNMT1, IGF1R, KDR, KIT, MET, MMP1, MMP9, SRC |
2.24188 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADORA2A, APP, CDC25B, FABP4, FLT3, HMGCR, IGF1R, KIT, PTPN1, SRC |
2.23619 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HMGCR |
2.21606 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, HSD17B2, KIT, MMP2, MMP9, SRC |
2.2142 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DNMT1, FABP3, HSD17B2, KDR, MMP2, SRC |
2.2142 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADORA2A, APP, AURKB, CDC25B, FABP4, FLT3, HMGCR, IGF1R, KIT, PTPN1, SRC |
2.21136 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADORA2A, APP, BCL2, CNR1, CSNK2A1, HCAR2, HMGCR, MMP12, PTPN1, SRC, TERT |
2.16211 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, FLT3, HMGCR, IGF1R, KDR, KIT, PTPN1, SRC, XDH |
2.1614 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
ADORA2A, AURKB, CA2, CA7, CNR1, HCAR2 |
2.1614 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.15787 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.13617 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADORA2A, CNR1, HCAR2, HMGCR, MMP12, SRC |
2.13432 |
[BP] GO:0050730 |
None
|
ADORA1, APP, FLT3, KIT, PTPN1, SRC |
2.11778 |
[BP] GO:0007568 |
aging
|
AURKB, BCL2, CNR1, CYP1A1, HMGCR, TERT |
2.11778 |
[BP] GO:0043086 |
negative regulation of catalytic activity
|
ADORA2A, APP, CNR1, CNR2, CSNK2A1, FABP4, HMGCR, IGF1R, MMP9, PTPN1, SRC |
2.10183 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.10104 |
[BP] GO:0035587 |
None
|
ADORA1, ADORA2A, ADORA3 |
2.10104 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ALPL, AXL, BCL2, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, HMGCR, KIT, MMP12, SRC, TYR |
2.0944 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, FLT3, HMGCR, IGF1R, KIT, PTPN1, SRC |
2.0944 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.08465 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CYP1B1, MMP9, SRC |
2.07402 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.0662 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ADORA2A, ALPL, APP, AXL, BCL2, CDC25B, CYP1A1, FABP4, FLT3, FUT7, HMGCR, KDR, KIT, MET, MMP2, MMP9, RORC, SRC, TERT |
2.04573 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.02944 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.02944 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, HMGCR |
2.02815 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC |
2.02815 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
ADORA2A, BCL2, CNR1, CYP1B1, HCAR2, HMGCR, MMP9, SRC, XDH |
2.02776 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, FLT3, RORC, SRC |
2.02721 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CYP1B1, DNMT1, IGF1R, MMP2, MMP9, RORC, SRC |
2.02721 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, ADORA2A, APP, BCL2, CA2, CA7, CNR1, MMP9 |
2.02721 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, F10, KIT, MET, SRC |
2.02372 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADORA2A, APP, AURKB, BCL2, CNR1, CSNK2A1, DNMT1, DYRK1A, FABP4, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
2.02151 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, FLT3, HMGCR, KDR, KIT, MMP9, PTPN1, SRC, XDH |
2.02151 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ADORA2A, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, DYRK1A, F10, FLT3, FUT7, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, SRC, TOP1 |
2.02138 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
2.02138 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
ADORA2A, BCL2, CNR1, CYP1B1, HCAR2, HMGCR, MMP9, SRC, XDH |
2.01305 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.01122 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA |
2.01097 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CHRM2, CNR1, CNR2, CSNK2A1, F10, FLT3, HCAR2, IGF1R, KDR, KIT, MET, MMP2, PIM1, PTPN1, SRC, TERT |
3.46626 |
[CC] GO:0016020 |
membrane
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, ALOX5, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, F10, FLT3, FUT7, HCAR2, HMGCR, HSD17B2, IGF1R, KDR, KIT, MET, MMP2, PIM1, PTPN1, SRC, TERT, TYR |
3.35885 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, F10, FLT3, FUT7, HCAR2, HMGCR, HSD17B2, IGF1R, KDR, KIT, MET, PTPN1, SRC, TYR |
2.8416 |
[CC] GO:0099056 |
None
|
ADORA1, ADORA2A |
2.4706 |
[CC] GO:0098889 |
None
|
ADORA1, ADORA2A |
2.4706 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA2A, ADORA3, APP, AXL, BACE1, CA4, CHRM2, CNR1, CNR2, F10, FLT3, IGF1R, KDR, MET |
2.38193 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BACE1, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, F10, FLT3, HMGCR, HSD17B2, PTPN1 |
2.3815 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ABCG2, ADORA1, ADORA2A, ADORA3, APP, AXL, BACE1, CA2, CA4, CA9, CHRM2, CNR1, CNR2, F10, FLT3, IGF1R, KDR, KIT, MET, SRC |
2.3815 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
11.0734 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, F10, FLT3, FUT7, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, SRC, TERT, TOP1, TYR, XDH |
10.7662 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.0568 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ABCG2, ACHE, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, F10, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TOP1, TYR, XDH |
8.78423 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.6649 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.38676 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ABCG2, ACHE, AURKB, AXL, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, PPARA, SRC, TOP1 |
6.15742 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.62693 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.35295 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
5.05234 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
4.8014 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.7704 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HMGCR, HSD17B1, HSD17B2, TYR, XDH |
4.73871 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
4.47636 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, F10, KIT, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TERT, TYR, XDH |
4.31811 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
4.31811 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, DNMT1, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC |
4.27081 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.26621 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
4.13717 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
4.09588 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, F10, KIT, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TERT, TYR, XDH |
4.02526 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
3.84264 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP1 |
3.74325 |
[MF] GO:0001609 |
None
|
ADORA1, ADORA2A, ADORA3 |
3.65384 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.45732 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HMGCR, HSD17B1, SRC, XDH |
3.34611 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.19615 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HMGCR, HSD17B1, HSD17B2, XDH |
3.15786 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP1 |
3.08684 |
[MF] GO:0042802 |
identical protein binding
|
ABCG2, ACHE, ADORA2A, APP, BCL2, CSNK2A1, DYRK1A, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP9, TERT, TYR, XDH |
2.95158 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ABCG2, ADORA1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP1, XDH |
2.87565 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.85789 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP1 |
2.75246 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, TERT, TOP1 |
2.74196 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA2A, ADORA3, AXL, CHRM2, CNR1, CNR2, FLT3, HCAR2, IGF1R, KDR, KIT, MET, PPARA, RORC |
2.63189 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, BACE1, CDC25B, CSNK2A1, DYRK1A, F10, FLT3, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, SRC, TOP1 |
2.56683 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.4706 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HMGCR, HSD17B1, HSD17B2 |
2.40062 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
2.29257 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ABCG2, APP, AURKB, AXL, CSNK2A1, DYRK1A, F10, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP1, XDH |
2.29176 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, ABCG2, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, FLT3, HMGCR, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP1, XDH |
2.27054 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, ABCG2, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, FLT3, HMGCR, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP1, XDH |
2.26971 |
[MF] GO:0035586 |
None
|
ADORA1, ADORA2A, ADORA3 |
2.22176 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA2A, ADORA3, AXL, CHRM2, CNR1, CNR2, FLT3, HCAR2, IGF1R, KDR, KIT, MET, PPARA, RORC |
2.18087 |
[MF] GO:0051721 |
None
|
BCL2, HMGCR, PTPN1 |
2.10104 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA2A, ADORA3, AXL, CHRM2, CNR1, CNR2, FLT3, HCAR2, IGF1R, KDR, KIT, MET, PPARA, RORC |
2.05638 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA2A, ADORA3, AXL, CHRM2, CNR1, CNR2, FLT3, HCAR2, IGF1R, KDR, KIT, MET |
2.02138 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA2A, ADORA3, AXL, CHRM2, CNR1, CNR2, FLT3, HCAR2, IGF1R, KDR, KIT, MET |
2.02138 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.00875 |